CNS Pharmaceuticals, Inc. (CNSP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.33M |
| Enterprise Value | -4.54M |
| P/E Ratio | -0.14 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 40.93 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.02 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -3.54 |
| Return On Equity | -2.39 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -15.83M |
| Net Income | -15.85M |
| Diluted EPS | -35.75 |
| Total Cash | 2.95M |
| Total Cash/Share | 4.36 |
| Total Debt | 232,353 |
| Total Debt/Equity | 3.29 |
| Current Ratio | 0.88 |
| Book Value Per Share | 0.1 |
| 52-Week Change | -53.02 |
| 52-Week High | 12.36 |
| 52-Week Low | 1.9 |
| Moving Average 50 Days | 4.39 |
| Moving Average 200 Days | 5.6 |
| Average Volume | 1.44M |
| Shares Outstanding | 574,580 |
| % Held by Institutions | 21.53 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | July 22, 2025 |